BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8575482)

  • 1. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
    Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
    Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction.
    Kauffman GJ; Boyne TS; Watson DD; Smith WH; Beller GA
    J Am Coll Cardiol; 1996 Jun; 27(7):1592-7. PubMed ID: 8636541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
    Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
    Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of prognostic value of 99mTc MIBI rest, 18F FDG and 201TL rest/redistribution on PTCA outcome of patients with moderate left ventricle dysfunction.
    Rossetti C; Landoni C; Lucignani G; Garraffa G; Ippolito M; Pepi M; Bartorelli A; Guazzi M; Savi A; Fazio F
    Panminerva Med; 1999 Sep; 41(3):199-206. PubMed ID: 10568116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of resting images from two myocardial perfusion tracers.
    Anagnostopoulos C; Laney R; Pennell D; Proukakis H; Underwood R
    Eur J Nucl Med; 1995 Sep; 22(9):1029-34. PubMed ID: 7588940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
    De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
    Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
    Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
    Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
    Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
    J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.
    Altehoefer C; Kaiser HJ; Dörr R; Feinendegen C; Beilin I; Uebis R; Buell U
    Eur J Nucl Med; 1992; 19(5):334-42. PubMed ID: 1612095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
    Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
    J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
    Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
    Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.
    Soufer R; Dey HM; Ng CK; Zaret BL
    Am J Cardiol; 1995 Jun; 75(17):1214-9. PubMed ID: 7778542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease.
    Kahn JK; McGhie I; Akers MS; Sills MN; Faber TL; Kulkarni PV; Willerson JT; Corbett JR
    Circulation; 1989 Jun; 79(6):1282-93. PubMed ID: 2785873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
    Brunken RC; Mody FV; Hawkins RA; Nienaber C; Phelps ME; Schelbert HR
    Circulation; 1992 Nov; 86(5):1357-69. PubMed ID: 1423947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Maurea S; Frank JA; Bonow RO
    Circulation; 1992 Oct; 86(4):1125-37. PubMed ID: 1394920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of myocardial perfusion and metabolism for assessment of myocardial viability.
    Beller GA
    Q J Nucl Med; 1996 Mar; 40(1):55-67. PubMed ID: 8681014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
    Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
    J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.